JOEL PHILLIPS: Open Payments
NPI 1811654007 · VALPARAISO, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,177 in 112 payments from 18 companies in 2025. Trend: 2023 $1,130 · 2024 $1,702 · 2025 $2,177
Food & beverage: $2,177
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 25 | $427 |
| Madrigal Pharmaceuticals | 10 | $335 |
| Takeda Pharmaceuticals U.S.A., Inc. | 15 | $329 |
| Janssen Biotech, Inc. | 18 | $220 |
| Phathom Pharmaceuticals, Inc. | 8 | $118 |
| Aimmune Therapeutics, Inc. | 4 | $101 |
| PFIZER INC. | 5 | $84 |
| GENZYME CORPORATION | 3 | $80 |
| VIVUS LLC | 4 | $73 |
| QOL Medical, LLC | 4 | $69 |
Products named: REZDIFFRA, RINVOQ, ENTYVIO, TREMFYA, VOQUEZNA, ZENPEP, LINZESS, PANCREAZE.
Industry payments across IN — which companies pay providers there.
